SCHEMBL2244628

SCHEMBL2244628

Cc1cncc(-c2cc(NCCc3c[nH]c4ccccc34)ncn2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 12/20 0.59
CYP2D6 P10635 11/20 0.59
CYP3A4 P08684 11/20 0.59
CYP2C19 P33261 11/20 0.59
CLK4 Q9HAZ1 10/20 0.59
USP2 O75604 9/20 0.59
ALOX15 P16050 7/20 0.59
ALDH1A1 P00352 7/20 0.59
HSD17B10 Q99714 5/20 0.59
CYP2C9 P11712 4/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
LMNA P02545 4/20 0.51
MAPK1 P28482 4/20 0.51
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.49
TSHR P16473 1/20 0.49
PTGS2 P35354 1/20 0.48
HTT P42858 2/20 0.47
GFER P55789 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2240377 0.83 GBA1 (0.47) CYP1A2CYP2D6CYP3A4CYP2C19CLK4
SCHEMBL26743855 0.77 EIF2AK2 (0.45) MEN1KMT2APTGS2HTR1AHTR2A
SCHEMBL26743868 0.75 GBA1 (0.74) CYP1A2CYP2D6CYP3A4CYP2C19CLK4
SCHEMBL21249043 0.74 GBA1 (0.43) CYP1A2CYP2D6CYP3A4CYP2C19CLK4
SCHEMBL21248401 0.74 GBA1 (0.45) CYP1A2CYP2D6CYP3A4CYP2C19CLK4
SCHEMBL34463054 0.73 CYP1A2 (0.60) CYP1A2CYP2D6CYP3A4CYP2C19CLK4
SCHEMBL28043713 0.73 HTR1A (0.53) ALDH1A1MEN1KMT2AMAPK1MAPT
SCHEMBL30278163 0.73 KMT2A (0.58) USP2ALOX15ALDH1A1MEN1KMT2A
SCHEMBL4775877 0.73 CYP3A4 (0.56) CYP1A2CYP2D6CYP3A4CYP2C19CLK4
SCHEMBL4771731 0.73 GBA1 (0.54) CYP1A2CYP2D6CYP3A4CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989458-B2 Pyrimidine derivatives as alk-5 inhibitors NOVARTIS AG (CH) 2011-08-02 US claimed